(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) CAD

Orexin A

Orexin A is a neuropeptide produced in the hypothalamus that plays a critical role in regulating wakefulness, arousal, and appetite. It binds to orexin receptors in the brain to promote alertness and maintain the sleep-wake cycle. Dysregulation of Orexin signaling is associated with sleep disorders like narcolepsy, cognitive performance and metabolic conditions.

What is Orexin A Peptide?

Orexin A, a neuropeptide produced by the lateral hypothalamus, has an effect by binding to two G-protein-coupled receptors, OX1R and OX2R, which are widely distributed in the brain. This binding activates intracellular signalling pathways, including the phospholipase C (PLC) and adenylate cyclase (AC) pathways, resulting in enhanced intracellular calcium levels and production of cyclic AMP (cAMP). This signalling cascade enhances neuronal excitability and synaptic transmission, which promote wakefulness, arousal, and energy homeostasis [1].

Orexin A neurons project to various brain regions, including the locus coeruleus, raphe nuclei, and thalamus, which are crucial for maintaining the sleep-wake cycle and regulating autonomic functions. By stimulating these areas, the Orexin A peptide sustains alertness and prevents the transition into sleep. Dysregulation of this mechanism, such as reduced orexin signalling, is linked to conditions like narcolepsy, characterized by excessive daytime sleepiness and cataplexy. Thus, Orexin A is vital for maintaining wakefulness and energy balance [2].

Potential Benefits of Orexin A Peptide Finland

Finland Research has indicated the following effects of Orexin A peptide:

  • Regulation of Wakefulness and Sleep – by promoting wakefulness and alertness by stimulating arousal centers in the brain, Orexin A could be a potential treatment for Narcolepsy [2].
  • Enhances Energy Homeostasis – Orexin A plays a role in regulating energy expenditure and metabolism, making it a potential treatment for metabolic disorders and obesity [3].
  • Improves Cognitive Function – Studies have found that the role of Orexin A may enhance attention, focus, and memory by modulating brain activity in regions associated with cognitive function. This may offer applications in neurogenerative diseases, including Alzheimer’s [4].
  • Mood regulation – Orexin A peptide influences the central nervous system, emotional states and stress responses, offering potential in managing anxiety and depression [5].

Buy Orexin A Peptide Finland for research purposes from PharmaGrade.Store.

Scientific Research on Orexin A Peptide Finland

Research on Orexin A peptide has significantly underpinned the understanding of its role in regulating wakefulness, energy balance, and various physiological processes. Recent studies have shown that Orexin A, produced in the hypothalamus, is critical for maintaining the sleep-wake cycle, with its dysfunction linked to narcolepsy—a condition which causes excessive sleepiness during the day time and cataplexy. Clinical trials targeting orexin receptors, such as dual orexin receptor antagonists (DORAs), have demonstrated promise for the treatment of insomnia by modulating orexin signalling [2].

Beyond sleep regulation, research has demonstrated Orexin A’s involvement in appetite regulation, energy expenditure, and reward pathways, making it a potential target for obesity and addiction therapies. Furthermore, preclinical studies also suggest its role in enhancing cognitive function, mood regulation, and neuroprotection, with implications for treating Alzheimer’s, depression, and anxiety [4]. While these findings are promising, ongoing research is needed to fully explore Orexin A’s therapeutic potential and address challenges in drug development and delivery.

Orexin A Specifications:

Sequence: XPLPDCCRQKTCSC RLYELLHGA GNHAAGILTL

Molecular Formula: C152H243N47O44S4

Molecular Weight: 3561.1 g/mol

Buy Orexin A Peptide Finland online for laboratory research use from PharmaGrade.Store today!

When purchasing the Orexin A peptide vial you will require Bacteriostatic Water for peptide reconstitution. Discover the full range of laboratory accessories for clinical use.

Frequently Asked Questions about Orexin A Peptide Finland

What is the difference between Orexin A and Orexin B peptides?

Orexin A and Orexin B belong to a family of hypothalamic neuropeptides, derived from the same precursor protein, prepro-orexin, but they differ in structure, receptor affinity, and physiological roles. Here’s a breakdown of the differences of the Orexin peptides:

  1. Structure:

    • Orexin A is a 33-amino acid peptide with two intrachain disulfide bonds, making it more stable and resistant to degradation.
    • Orexin B is a 28-amino acid linear peptide without disulfide bonds, making it less stable compared to Orexin A.
  2. Receptor Affinity:

    • Orexin A binds to both orexin receptors, OX1R and OX2R, with high affinity.
    • Orexin B primarily binds to OX2R with higher affinity and has a weaker interaction with OX1R.
  3. Physiological Roles:

    • Orexin A is more broadly involved in wakefulness, arousal, and energy homeostasis.
    • Orexin B is more specifically linked to sleep regulation, particularly through its action on OX2R.
  4. Stability and Function:

    • Orexin A’s stability allows it to have a more prolonged effect, while Orexin B’s shorter half-life limits its duration of action.

 

Can Orexin A peptide help manage Anxiety?

Orexin A shows potential in managing anxiety, though its role is complex and still under investigation. Research suggests that Orexin A influences emotional regulation and stress responses by acting on brain regions like the amygdala, hypothalamus, and prefrontal cortex, which are critical for processing fear and anxiety.

Can Orexin A peptide help with weight loss?

Orexin A has potential implications for weight loss due to its role in regulating appetite, energy expenditure, and metabolism. However, its effects are complex and not fully understood. Here’s how Orexin A might contribute to weight management:

  1. Appetite Regulation:

    • Orexin A interacts with brain regions like the hypothalamus to influence hunger and satiety. It may help suppress appetite or modulate food intake, particularly in response to energy needs.
  2. Increased Energy Expenditure:

    • Orexin A promotes physical activity and thermogenesis (heat production), which can increase calorie burning. It stimulates arousal and wakefulness, potentially leading to more active behaviors.
  3. Fat Metabolism:

    • Studies suggest that Orexin A may enhance lipid metabolism, encouraging the body to use fat (adipose tissue) as an energy source.
  4. Circadian Rhythm and Eating Patterns:

    • By regulating the sleep-wake cycle, Orexin A may help align feeding behavior with natural circadian rhythms, reducing late-night eating or irregular meal patterns.

While these mechanisms suggest Orexin A could aid in weight loss, there are important considerations:

  • Dysregulation of the orexin system has been linked to obesity, but overactivation could lead to stress or anxiety, which might negatively impact weight management.
  • Therapeutic applications targeting Orexin A are still in early stages, and more research is needed to determine its safety and efficacy for weight loss.
 
What is Orexin deficiency?
 
Orexin deficiency refers to a condition where the human brain produces insufficient levels of orexin (also known as hypocretin), a neuropeptide that plays a critical role in regulating wakefulness, arousal, and appetite. Orexin is produced in the hypothalamus, plays an important role in maintaining the sleep-wake cycle, regulation of sleep and other physiological processes. A deficiency in orexin in the human brain is most commonly associated with narcolepsy type 1, a sleep disorder characterized by excessive daytime sleepiness and cataplexy (sudden muscle weakness triggered by strong emotions).
 
What the role of the orexin system?
 
The orexin system (also known as the hypocretin system) plays a critical role in regulating several physiological and behavioral processes, particularly those related to wakefulness, energy balance, and arousal. It consists of two neuropeptides, Orexin A and Orexin B, which are produced in the hypothalamus and act on two receptors, OX1R and OX2R.
 
What are the potential side effects or risks associated with Orexin A peptide?
 

Orexin A peptide shows promise for treating conditions like narcolepsy, cognitive impairments, and metabolic disorders, but its use comes with potential risks and side effects. As it promotes wakefulness and arousal, overstimulation of the nervous system could lead to insomnia, restlessness, or heightened anxiety. It may also activate the stress response, increasing cortisol levels and exacerbating anxiety in susceptible individuals. Additionally, animal studies have indicated that Orexin A can raise heart rate and blood pressure, posing risks for those with cardiovascular conditions.

Other potential side effects include appetite dysregulation, which could lead to overeating or weight gain, and sleep disruption if administered at inappropriate times. Long-term use may result in tolerance or dependency, while allergic reactions or interactions with other medications are also possible. Since scientific laboratory research on Orexin A as form of therapeutic application are still in experimental stages, their long-term safety profile remains unclear.

PharmaGrade.Store supplies research grade peptide for laboratory experimentation only.

 

Further Reading:

Blogs:

The blog discusses the potential of peptides like DSIP, Semax, and Adamax in addressing narcolepsy, a disorder marked by disrupted sleep cycles, excessive fatigue, and cognitive challenges. It explores how DSIP may stabilize deep sleep, Semax could enhance focus and neurotransmitter balance, and Adamax might boost energy and motivation. 

The blog explores how the Orexin A Antibody is used in research to study its pathways. It highlights how Orexin A supports wakefulness and neurotransmitter activity, while its disruption can lead to fatigue and cognitive challenges. The article also examines complementary peptides like NAD+, Semax, Adamax, and Selank, which are studied for their potential to enhance energy, focus, and stress resilience, offering insights into the molecular mechanisms behind cognitive performance.

Scientific Research:

[1] Jászberényi M, Thurzó B, Bagosi Z, Vécsei L, Tanaka M. The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress. Biomedicines. 2024 Feb 17;12(2):448.

[2] Katzman MA, Katzman MP. Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone. Brain Sci. 2022 Jan 24;12(2):150. 

[3] Butterick TA, Billington CJ, Kotz CM, Nixon JP. Orexin: pathways to obesity resistance? Rev Endocr Metab Disord. 2013 Dec;14(4):357-64.

[4] Um YH, Lim HK. Orexin and Alzheimer’s Disease: A New Perspective. Psychiatry Investig. 2020 Jul;17(7):621-626. 

[5] Grafe LA, Bhatnagar S. Orexins and stress. Front Neuroendocrinol. 2018 Oct;51:132-145.

Buy Orexin A Peptide Finland Online from PharmaGrade.Store

High Quality Peptides

1. Choose Product

Select your preferred product based on your research objectives.

Great Prices

2. Safe, effective products

PharmaGrade.Store supplies high purity research peptides globally.

High Quality Peptides

3. Cost effect and Reliable Delivery

Products are dispensed quickly and delivered worldwide.

ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY

DISCLAIMER: All products sold by PharmaGrade.Store are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals